The News
6WIND emporers customers and partners with a further commitment to quality
30/07/2004
Paris, July 30, 2004 – 6WIND today launched its “Powered by 6WINDTM” quality assurance label to provide the company’s valued customers and partners the assurance of receiving best-in-class secure and robust networking solution.
This trademarked quality label has been designed to certify that any networking solution of 6WIND customers or partners using the 6WINDGate software has undergone stringent porting, integration and tests suites, carefully developed by 6WIND engineers to adhere to established industry standards worldwide. Close to 4000 automated integration tests and use case scenarios, incorporating stringent test standards from international and local tests consortiums, enable 6WIND partners and customers to cut down end-product time-to-market by an estimated 30 percent. This quality assurance process also speeds up the integration of new functionalities into a networking product by three times and reduces overall man-hours, significantly lowering overall development costs.
The label carries the association with 6WINDGate’s IPv6-ready certification by the global IPv6 Forum’s logo committee, as well as its award-winning and patented technology which has been successfully deployed in more than 80 advanced IP networking projects around the world. Customers and partners who have received the quality assurance of being “powered by 6WIND” can be certain of using a feature-rich, future-proof, intelligent and mature IP communication piece that differentiates their products to be fully equipped for today’s and tomorrow’s networking needs.
“The Powered by 6WIND quality label has been introduced to further extend our commitment to our customers and partners who have chosen to integrate 6WINDGate software into their networking products. They can rest assured that we take all necessary measures to lower their risks in producing a quality and marketable end-product. This label is neither a corporate brand nor logo but an attestation to the wealth of expertise and innovation surrounding the development of a networking device integrating the 6WINDGate IP networking software”, said Eric Carmès, 6WIND’s Chief Operating Officer.
For further information on 6WIND quality assurance label, visit http://www.6wind.com
About 6WIND
Considered a key reference in IP technologies, 6WIND is a leader and innovator of advanced IP networking software. 6WIND’s fully-integrated IPv4-IPv6 flagship software, the 6WINDGate™, significantly shortens development time and costs, reduces network integration issues, speeds up time to market and delivers a leading edge differentiator. Its open architecture and rich IP functionalities empower easy integration of third party applications and facilitates development of advanced multifunction IP networking equipment, representing a valuable future-proof investment for deploying value-added IP services i.e. secure broadband access, WLAN, mobility and multimedia applications. End-users of the 6WINDGate™ include major industrial corporations, ISPs and telecommunication operators, public services and state bodies as well as the academia.
6WIND is a spin-off of Thales and a major contributor to IETF (Internet Engineering Task Force) on IP standardization and protocol definition. An award-winner of Europe’s prestigious IST 2004 (Information Society Technology) prize for groundbreaking technologies, 6WIND was also the first European company certified IPv6-ready by the global IPv6 Forum. 6WIND is headquartered near Paris, France, and is present in Asia.
Press Contact:
Anne-Lise Veyssière
anne-lise.veyssiere@6wind.com
tel: +33 1 39 30 92 29 is now nearly 20 years old. IPv4 has been remarkably resilient in spite of its efficient network route aggregation at the global backbone level.
2004
- 21/01/2004
- 21/01/2004
- 28/01/2004
- 26/01/2004
- 26/01/2004
- 29/01/2004
-
29/01/2004
Sofinnova Partners investit dans InfraWorlds, société à fort potentiel
- 09/02/2004
- 09/02/2004
- 16/02/2004
- 25/02/2004
- 25/02/2004
-
26/02/2004
Esmertec gains a worldwide leadership role in fast growing mobile Java™ markets
- 24/02/2004
- 24/02/2004
-
23/02/2004
SOFINNOVA earmarks €85 million to accelerate activity in European wireless market
- 04/03/2004
- 08/03/2004
- 17/03/2004
- 08/03/2004
- 18/03/2004
- 29/03/2004
- 29/03/2004
-
07/04/2004
Esmertec™ provides Time Warner Cable with JVM solution for the OCAP Market
- 06/04/2004
- 06/04/2004
- 20/04/2004
- 21/04/2004
- 27/04/2004
-
03/05/2004
Vidiom Systems Selects Esmertec™ to provide the JVM solution for its OCAP Products
-
05/05/2004
Georges Haas, Ph.D., Joins Ingenium’s Supervisory Board Munich, Germany, May 5, 2004
-
10/05/2004
Faust raises 16 million euros to further develop its product candidates
-
10/05/2004
Faust Pharmaceuticals lève 16 M d’euros pour développer ses produits en clinique
-
03/05/2004
Saegis Pharmaceuticals Begins Phase II Clinical Trial of SGS742 for Alzheimer’s Disease
- 28/04/2004
-
12/05/2004
Ingenium Acquires Pivotal Patents for INGENOtypingTM Platform
-
17/05/2004
Addex Pharmaceuticals Completes Largest ever European Biotech Series B Fund Raising
- 19/05/2004
- 25/05/2004
- 10/06/2004
- 07/06/2004
- 22/06/2004
- 07/06/2004
- 14/06/2004
-
14/06/2004
TRISENOX® Produces Hematologic Responses in 27 Percent of MDS Patients
-
22/06/2004
Esmertec to demonstrate new breakthrough Java™ Solution – Jbed™ Advanced during JavaOne 2004
- 22/06/2004
-
28/06/2004
Esmertec’s Java™ Virtual Machine (JVM) solution for mobile phones is selected by Panasonic
- 01/07/2004
- 23/06/2004
-
06/07/2004
Atomz Named to Second-Annual AlwaysOnTM List of Top 100 Private Companies
- 30/06/2004
-
12/07/2004
Qosmos reçoit un premier tour de financement de Sofinnova Partners
-
12/07/2004
Qosmos receives a first round of financing from Sofinnova Partners
-
07/07/2004
Esmertec ouvre un centre d'assistance clientèle et de test à Taipei (Taiwan)
-
07/07/2004
Esmertec is opening Customer Support and Testing Centre in Taipei, Taiwan
-
19/07/2004
Ablynx and Procter&Gamble form nanobody drug discovery and development partnership
- 22/07/2004
- 20/07/2004
-
22/07/2004
Esmertec welcomes Michel Bon, Former CEO and Chairman of France Telecom, to its Board
-
26/07/2004
Cell Therapeutics, Inc. Completes Enrollment in Third Pivotal Trial of XYOTAX™ in Lung Cancer
- 26/07/2004
-
28/07/2004
Diatos Elected Among the Top 15 Emerging Biotech Companies of 2004
-
30/07/2004
6WIND emporers customers and partners with a further commitment to quality
-
02/08/2004
Les plus hautes performances Java jamais atteintes sur cœur de MIPS32 24Kc
-
02/08/2004
Highest Java™ Performance Achieved by the MIPS32® 24Kc™ Core
- 27/07/2004
- 27/07/2004
- 16/08/2004
-
09/08/2004
"Euronext n'a pas la place financière qu'il mérite" Jean-Bernard Schmidt - Les Echos 9 Août 2004 -
-
30/08/2004
Tony Reis, l’ancien CEO de Swisscom, rejoint le Conseil d’Administration d’Esmertec
-
30/08/2004
Tony Reis, Former CEO of Swisscom, joins Esmertec’s Board of Directors
-
24/08/2004
Enfora partners with Esmertec to enable wireless Java technology in their GSM/GPRS OEM devices
-
24/08/2004
Enfora se rapproche d’Esmertec pour intégrer la technologie Java dans ses terminaux GSM/GPRS
-
16/08/2004
Intransa secures twenty five million dollars in series D funding
-
06/09/2004
Sensitive Object secures 2 million € Series A financing round from Sofinnova Partners
- 06/09/2004
-
08/09/2004
Oxxius reçoit un premier financement de 2,4 millions d'euros de Sofinnova Partners
-
14/09/2004
Le Dr Ulrich Schumacher rejoint le Conseil d’Administration d’Esmertec
-
08/09/2004
Oxxius receives 2.4 million euros from Sofinnova Partners in first round of financing
-
14/09/2004
Dr. Ulrich Schumacher joins Esmertec as a Member of the Board of Directors
- 20/09/2004
- 23/09/2004
-
23/09/2004
France Telecom selects Esmertec as technology partner for its embedded Java platforms
- 30/09/2004
- 30/09/2004
-
26/10/2004
Esmertec lève CHF 23.5 Millions par le biais d’obligations convertibles
-
26/10/2004
Esmertec raises CHF 23.5 Million from convertible note to fund growth
-
26/10/2004
Intransa annouces IP5500 - The industry's next-generation modular IP san solution for the mid-market
-
10/11/2004
Varioptic Selected Most Innovative Company of the Year for Its Liquid Lenses
-
10/11/2004
Varioptic élue Entreprise Innovante de l’année pour ses lentilles liquides
- 18/11/2004
-
18/11/2004
Esmertec Establishes Strategic Relationship with Mitsui & Co.
- 17/11/2004
-
22/11/2004
Ablynx appoints Edwin Moses as chairman of the board of directors
-
23/11/2004
Sendo choisit la solution Java d’Esmertec’s pour ses téléphones mobiles
-
23/11/2004
Sendo has chosen Esmertec’s Java solution for its mobile phones
- 23/11/2004
- 06/12/2004
-
05/12/2004
TRISENOX® Produces Hematologic Responses in 30 Percent of Patients with Higher-Risk MDS
-
09/12/2004
Esmertec to Integrate Hybrid’s OpenGL ES based Graphics Solutions into its Jbed Solution
-
16/12/2004
Diatos moves its lead drug, DTS-201, toward clinical trials in Europe
- 23/12/2004
- 16/12/2004
- 01/11/2004
-
16/12/2004
Esmertec to further secure mobile Java content with SATSA-based implementation from Gemplus
-
16/12/2004
Esmertec sécurise les contenus des mobiles Java avec l’implémentation SATSA de Gemplus